Skip to main content
Livermore
Livermore
ZHEN

Ancora Advisors, LLC

SEC CIK
0001446114
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Ancora Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of BMRN by Ancora Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−702−100.0%Sold outHolders
Q4 2025702$41.7K<0.1%−216−23.5%ReducedHolders
Q3 2025918$49.7K<0.1%00.0%UnchangedHolders
Q2 2025918$50.5K<0.1%−75−7.6%ReducedHolders
Q1 2025993$70.2K<0.1%−300−23.2%ReducedHolders
Q4 20241,293$85.0K<0.1%−350−21.3%ReducedHolders
Q3 20241,643$115.5K<0.1%−150−8.4%ReducedHolders
Q2 20241,793$147.6K<0.1%00.0%UnchangedHolders
Q1 20241,793$156.6K<0.1%+43+2.5%AddedHolders
Q4 20231,750$168.7K<0.1%−150−7.9%ReducedHolders
Q3 20231,900$168.1K<0.1%00.0%UnchangedHolders
Q2 20231,900$164.7K<0.1%00.0%UnchangedHolders
Q1 20231,900$184.8K<0.1%00.0%UnchangedHolders
Q4 20221,900$197.0K<0.1%−200−9.5%ReducedHolders
Q3 20222,100$178.0K<0.1%−25−1.2%ReducedHolders
Q2 20222,125$176.0K<0.1%−91−4.1%ReducedHolders
Q1 20222,216$171.0K<0.1%−125−5.3%ReducedHolders
Q4 20212,341$207.0K<0.1%+1,916+450.8%AddedHolders
Q3 2021425$33.0K<0.1%+350+466.7%AddedHolders
Q2 202175$6.00K<0.1%00.0%UnchangedHolders
Q1 202175$6.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.